Trials evaluating the omission of completion axillary-lymph-node dissection in patients with clinically node-negative breast cancer and sentinel-lymph-node metastases have been compromised by limited ...
The Melanoma Institute of Australia (MIA) previously developed a risk calculator for sentinel lymph node (SLN) metastasis risk to help clinicians and patients with primary cutaneous melanoma decide ...
The SenSzi (GBG80) Trial 1 has assessed the contribution of information derived from lymphoscintigraphy in improving the performance of the sentinel lymph node (SLN) biopsy procedure in cN0 breast ...
Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations Genes with functional roles in melanoma metastasis were discovered by analysis of next-generation sequencing ...
Please provide your email address to receive an email when new articles are posted on . Skipping sentinel lymph node biopsy can be considered for node-negative, HR-positive, HER2-negative early breast ...
Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...